title: Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study.
abstract: BACKGROUND
  The use of oral anticoagulant therapy (OAT) to prevent non-valvular atrial fibrillation (NVAF) related-strokes is often sub-optimal. We aimed to evaluate whether implementing guidelines on antithrombotic therapy (AT) by a multifaceted strategy may improve appropriateness of its prescription in NVAF-patients discharged from a large tertiary-care hospital.
  
  
  METHODS
  A survey was conducted on all consecutive NVAF patients discharged before (1st January-30th June 2000, n = 313) and after (1st January-30th June 2004, n = 388) guideline development and implementation.
  
  
  RESULTS
  When strongly recommended, OAT use increased from 56.6% (60/106 in 2000) to 81.9% (86/105 in 2004), with an absolute difference of +25.3% (95%CI: 15% 35%). In patients for whom the choice OAT/acetylsalicylic acid should be individualised, those discharged without any AT were 33.7% (34/101) in 2000 and 16.9% (21/124) in 2004 (-16.7%;95%CI: -26.2% -7.2%). In a logistic regression model, OAT prescription in 2004 was increased by 2.11 times (95%CI: 1.47 3.04), after accounting for stroke risk, presence of contraindications (OR = 0.18; 0.13 0.27), older age (OR = 0.30; 0.21 0.45), prophylaxis at admission (OR = 3.03; 2.08 4.43). OAT was positively associated with the stroke risk in the 2004 sample only.
  
  
  CONCLUSIONS
  The guideline implementation has substantially improved the appropriateness of OAT at discharge, through a better evaluation at patient's individual level of the benefit-to-risk ratio.
authors: Department of Internal Medicine, University of Torino, Italy. sbo@molinette.piemonte.it
authors: Simona
authors: S
authors: Bo
authors: Susanna
authors: S
authors: Valpreda
authors: Luca
authors: L
authors: Scaglione
authors: Daniela
authors: D
authors: Boscolo
authors: Marina
authors: M
authors: Piobbici
authors: Mario
authors: M
authors: Bo
authors: Giovannino
authors: G
authors: Ciccone
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D018890:Chemoprevention; D000075202:Contraindications; D017723:Drug Utilization Review; D005260:Female; D015577:Geriatric Assessment; D006784:Hospitals, Teaching / Q000592:standards*; D006801:Humans; D007558:Italy; D016015:Logistic Models; D008297:Male; D010351:Patient Discharge; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000150:complications / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin
references: Thromb Res. 2007;121(3):347-52
references: 17597186
references: Lancet. 1996 Aug 17;348(9025):423-8
references: 8709780
references: Postgrad Med J. 2000 Dec;76(902):783-6
references: 11085769
references: Heart. 1999 Nov;82(5):539-40
references: 10525502
references: J Am Coll Cardiol. 2003 Jan 1;41(1):56-61
references: 12570945
references: Arch Intern Med. 2005 Jul 11;165(13):1455-6
references: 16009859
references: Prev Med. 2004 Feb;38(2):121-8
references: 14715203
references: Arch Intern Med. 2001 Sep 24;161(17):2125-8
references: 11570942
references: Arch Intern Med. 1998 Oct 26;158(19):2093-100
references: 9801175
references: Age Ageing. 2002 Sep;31(5):391-6
references: 12242203
references: J Am Coll Cardiol. 2005 Nov 1;46(9):1729-36
references: 16256877
references: Prev Med. 2005 Sep-Oct;41(3-4):791-4
references: 16102802
references: JAMA. 2001 Jun 13;285(22):2864-70
references: 11401607
references: Jt Comm J Qual Improv. 2000 Jan;26(1):18-28
references: 10677819
references: Ann Intern Med. 1999 Nov 2;131(9):688-95
references: 10577332
references: Eur Heart J. 2006 Aug;27(16):1954-64
references: 16847008
references: JAMA. 2002 Nov 20;288(19):2441-8
references: 12435257
references: Lancet. 1998 Oct 10;352(9135):1167-71
references: 9777832
references: Haematologica. 2005 May;90(5):678-84
references: 15921383
references: J Am Coll Cardiol. 2000 Jan;35(1):183-7
references: 10636278
references: Ann Intern Med. 1999 Dec 21;131(12):927-34
references: 10610643
references: G Ital Cardiol (Rome). 2013 Jan;14(1):21-34
references: 23258202
references: Circulation. 2003 Aug 12;108(6):711-6
references: 12885749
references: Ann Emerg Med. 2004 Jul;44(1):3-11
references: 15226703
references: Chest. 1998 Nov;114(5 Suppl):579S-589S
references: 9822064
references: Ann Pharmacother. 2004 Nov;38(11):1794-9
references: 15454583
references: J Am Geriatr Soc. 2005 Nov;53(11):1912-20
references: 16274372
references: J Am Coll Cardiol. 2006 Aug 15;48(4):854-906
references: 16904574
references: Arch Intern Med. 2000 Jan 10;160(1):41-6
references: 10632303
references: Heart. 2003 May;89(5):553-4
references: 12695466
references: CMAJ. 2005 Aug 30;173(5):496-501
references: 16129870